|
|
|
|
|
|
|
|
|
News | News By Subject |
News By Date | Search News
|
|
|
Print
Email
6/19/2012 10:10:14 AM
DENVER & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC: CONX.OB) (“Corgenix Medical”), a worldwide developer and marketer of diagnostic test kits, today announced that its wholly owned subsidiary, Corgenix, Inc. (Corgenix, Inc., together with Corgenix Medical, are herein referred to as “Corgenix”), entered into a contract manufacturing and supply agreement with diaDexus, Inc. (OTC: DDXS) (“diaDexus”), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products. Under the terms of the five-year agreement, Corgenix will manufacture and supply the PLAC® Test ELISA product for diaDexus.
|
Read Article at |
Related Companies |
News Categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|